LabReady® is redefining the 85-year-old specimen collection process–leading to faster, more reliable diagnoses. The company has automated and compressed the required sample enrichment process bacterial and viral specimens down to a 2.5-ounce, handheld device that can be used by physicians, nurses, and consumers to screen for infection without the need for a high-complexity lab. Our patented, CE marked Automated Sample Prep System® enriches bacterial specimens with zero hands-on time before it reaches the lab.

By eliminating the need for manual enrichment, labs can redeploy resources to more value-added activities, improving workflow. Samples collected with LabReady don’t need to be shipped under cold-chain and remained viable at 10⁹ CFUs for 14 days without refrigeration. You also benefit from eliminating the errors that can result from pre-analytical work while increasing margins. Additionally, lower skilled employees can simply screen infection samples with LabReady’s Enriched Rapid Test System™. 

Medical Devices

Vax-Immune Diagnostics

Leonard E. Weisman, MD

Tom Renner

Scott Miller

Eileen Weisman

Sarah Ihle, MBA

Tom Lagatta

Andrew Rogovin, JD

James Remenick, JD

Kevin Lovins, CPA

Jeannette Underwood

Phil Weiner

The Finance and Accounting Team at Vax-Immune Diagnostics is responsible for managing the company's financial health, ensuring accurate financial reporting, and overseeing budget planning and control. The team handles bookkeeping, prepares financial statements, and supports strategic financial decision-making to enhance business operations and profitability. Led by the Chief Financial Officer (CFO) and supported by external bookkeepers and accountants, the team ensures compliance with financial regulations and optimizes the allocation of resources.

Finance and Accounting Team

Leadership Team

Quality Assurance & Regulatory Affairs

Finance and Accounting Team

About

Team members

Other teams at Vax-Immune Diagnostics

Leadership Team

Quality Assurance & Regulatory Affairs